A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2006
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141572 For therapy of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS
11/28/2006	US7141567 such as (7R,8R,9R)-8-hydroxy-2-methyl-7-(2-methoxyethoxy)-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridine; for treatment of gastrointestinal disorders
11/28/2006	US7141558 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
11/28/2006	US7141557 Lipid analogs for treating viral infections
11/28/2006	US7141555 Water solubility, bioavailability, oral administration; unit dosage
11/28/2006	US7141554 Method of treating irritable bowel syndrome
11/28/2006	US7141363 Purposeful movement of human migratory cells away from an agent source
11/28/2006	US7141262 Using microfiltration and/or diafiltration to isolate transforming growth factor from dairy products for use in treatment and prevention of cell proliferative, autoimmune, bone and inflammatory disorders; antitumor agents
11/28/2006	CA2379786C Purine derivatives
11/28/2006	CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006	CA2375524C 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/28/2006	CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
11/28/2006	CA2314775C Novel lactic acid bacterial preparation that reduces triglycerides and cholesterol
11/28/2006	CA2160444C Aroyl-piperdine derivatives
11/28/2006	CA2035888C Nucleic acid coding for human testicular angiotensin (eca) conversion enzyme, its applications, in particular for in vitro screening of this enzyme in the organism
11/23/2006	WO2006124753A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature
11/23/2006	WO2006123724A1 Novel pharmaceutical using anti-hla antibody
11/23/2006	WO2006123644A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF
11/23/2006	WO2006123639A1 Pyrimidine derivative
11/23/2006	WO2006123618A1 Oxidative stress inhibitor
11/23/2006	WO2006123550A1 Prophylactic or therapeutic agent for inflammatory disease
11/23/2006	WO2006123466A1 Drugs, food or drink for improving pancreatic functions
11/23/2006	WO2006123465A1 Drugs, food or drink for improving pancreatic functions
11/23/2006	WO2006123464A1 Drugs, food or drink for improving pancreatic functions
11/23/2006	WO2006123430A1 Dental enamel recalcification accelerator and containing the same, oral composition and food or beverage
11/23/2006	WO2006123238A1 Confectionery products for the treatment of dry mouth
11/23/2006	WO2006123060A1 Novel food ingredient and products containing the same
11/23/2006	WO2006123058A1 Medicament made from laminarine or oligolaminarines for treatment of viral hepatitis
11/23/2006	WO2006122925A2 Oral medicament based on a proton pump inhibitors
11/23/2006	WO2006033081A3 Peroxisome proliferation receptor agonists, for the treatment of gastritis
11/23/2006	US20060264468 Use of substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections
11/23/2006	US20060264456 Phosphorus-containing compounds & uses thereof
11/23/2006	US20060264436 Method of Treating a Psychotic Disorder
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	US20060264432 Adenosine A1, A2a, and A2b receptor ligands; coupling the 2-mercapto-3,5-dicyano-4-aryl-6-aminopyridine to a substituted alkyl or alkenyl compound; antiischemic agents; cardiovascular disorders
11/23/2006	US20060264408 Sod minic multifunctional compounds for treating inflammatory bowel disease
11/23/2006	US20060264397 Compositions and methods for targeting cancer cells
11/23/2006	US20060264390 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
11/23/2006	US20060264389 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
11/23/2006	US20060264354 Cop 1 for treatment of inflammatory bowel diseases
11/23/2006	US20060263881 Methods of expanding and selecting disease associated T-Cells
11/23/2006	US20060263849 The analogs are resistant to diaminopeptidase IV degradation and bind zinc; are active over an extended time in vivo
11/23/2006	US20060263781 Regulation of cell surface proteins
11/23/2006	US20060263426 Oral administration form for pyridin-2-ylmethysulfinyl-1h-bezimidazoles
11/23/2006	US20060263359 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4)
11/23/2006	US20060263305 Using azithromycin antibiotic
11/23/2006	DE102005023207A1 New heteroaryl derivatives are phosphodiesterase-4 enzyme inhibitors useful for the treatment of e.g. respiratory or gastrointestinal complaints or diseases, depression, Alzheimer's disease and Parkinson's disease
11/23/2006	CA2609102A1 Int6 protein involved in hypoxia stress induction and use thereof
11/23/2006	CA2608577A1 Confectionery products for the treatment of dry mouth
11/23/2006	CA2608447A1 Oxidative stress inhibitor
11/23/2006	CA2608185A1 Oral medicament based on a proton pump inhibitors
11/23/2006	CA2607472A1 Antipyretic agents against vr1-antagonist-induced increases in body temperature
11/22/2006	EP1724270A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/22/2006	EP1724268A1 Compound having tgf-beta inhibitory activity and pharmaceutical composition containing same
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1724264A1 Nitriles and medicinal compositions containing the same as the active ingredient
11/22/2006	EP1723959A1 Composition comprising platelet-rich plasma
11/22/2006	EP1723954A1 Indazole derivatives for the treatment of cancer
11/22/2006	EP1723854A1 Beverage or drug containing bamboo extract as main ingredient
11/22/2006	EP1722794A1 Methods and compositions for the treatment of conditions related to gastric acid secretion
11/22/2006	EP1722768A2 Medicaments for treating barrett's oesophagus
11/22/2006	EP1722740A1 Method of treating a patient's teeth using fluoride releasing glass composition
11/22/2006	EP1467982B1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
11/22/2006	EP1461034B1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
11/22/2006	EP1458683B1 Heteroaryl-substituted aminocyclohexane derivatives
11/22/2006	EP1438055A4 D-tagatose as an anti-biofilm agent
11/22/2006	EP1390360B1 Crystalline form of omeprazole
11/22/2006	EP1360186B1 Carboline derivatives
11/22/2006	EP1351933B1 Il-8 receptor antagonists
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1294757B1 Glucagon-like peptide-1 analogs
11/22/2006	EP1277752B1 Process for producing optically active sulfoxide derivative
11/22/2006	EP1268435B1 4,5-dihydro-1h-pyrazole derivatives having cb 1-antagonistic activity
11/22/2006	EP1173465B1 Novel human voltage-gated potassium channel
11/22/2006	EP1146899B1 Methods of using neurotrophin 3 (nt-3) for the treatment of gastrointestinal hypomotility disorders
11/22/2006	EP1096924B1 Inhibitors of proteasomal activity for stimulating hair growth
11/22/2006	EP1078054B1 Monomeric mp52/gdf-5 with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
11/22/2006	EP1073462B1 Combined vaccine against Hepatitis A and Hepatitis B
11/22/2006	EP1066247B1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
11/22/2006	EP1051395B1 N-hydroxyformamide derivatives
11/22/2006	CN1867345A Therapeutic agent for periodontal disease
11/22/2006	CN1865442A SiRNA sequence aimed at hepatitis B virus gene and its uses
11/22/2006	CN1865427A Health medicine liquor and its preparation method
11/22/2006	CN1864746A Gene engineered poly-valence subunit vaccine of Hp AhpC and preparation method thereof
11/22/2006	CN1864741A 'Huo Xiang Zheng Qi' essence powder for poultry and livestock, its preparation process and application method
11/22/2006	CN1864733A Chinese proprietary medicine for treating oral cavity inflammation
11/22/2006	CN1864727A A medicine for treating chronic gastritis
11/22/2006	CN1864715A Chinese medicinal preparation for treating stomatocace and preparation method thereof
11/22/2006	CN1864709A Constipation relieving powder and preparation method thereof
11/22/2006	CN1864698A Capsule for treating gastric disease and preparation process thereof
11/22/2006	CN1864663A Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2 (11),3,5,7,9-pentaene
11/22/2006	CN1285610C Human liver regeneration promoting factor derivative and its expression
11/22/2006	CN1285593C Pyrrolopyridazine compound
11/22/2006	CN1285578C Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
11/22/2006	CN1285572C Cannabinod receptor ligands
11/22/2006	CN1285380C Chinese proprietary medicines for treating epiagstric pain and preparation method thereof
11/22/2006	CN1285378C Nourishing wine for regulating human body balance function
11/22/2006	CN1285376C Chinese herbal medicines for various stones and their preparation
11/22/2006	CN1285373C Stomach and intestine root securing mixture having sea buckthorn oil

1 ... 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 ... 1258